Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Technology
History
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/8f/ae/cc/8faecc85-d826-5021-7470-d2c13c624032/mza_17175205483138105221.jpg/600x600bb.jpg
PayerTalkCE
IMPACT
37 episodes
6 months ago
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
Show more...
Courses
Education
RSS
All content for PayerTalkCE is the property of IMPACT and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
Show more...
Courses
Education
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/8f/ae/cc/8faecc85-d826-5021-7470-d2c13c624032/mza_17175205483138105221.jpg/600x600bb.jpg
PayerTalkCE™ Presents: Balancing Cost and Access to Quality Care for Therapeutic Advancements in Psoriasis
PayerTalkCE
45 minutes 51 seconds
1 year ago
PayerTalkCE™ Presents: Balancing Cost and Access to Quality Care for Therapeutic Advancements in Psoriasis
Jim Kenney (formerly of Harvard Pilgrim) leads a discussion on advancements in psoriasis treatment, emphasizing the need for early diagnosis and tailored care, especially for skin of color patients who may face diagnostic delays. Joined by Dr. Heather Woolery-Lloyd (Johns Hopkins School of Medicine) and Jason Harris (National Psoriasis Foundation), the conversation covers the broad spectrum of psoriasis treatments, from topical therapies to biologics, and highlights the importance of considering patient preferences and comorbidities in treatment planning. They also discuss the challenges of access to care, the impact of psoriasis on mental health, and the evolving landscape of treatment options, emphasizing a multidisciplinary approach to manage this complex condition effectively.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/psoriasis-advancements/ (https://www.impactedu.net/psoriasis-advancements/). 
PayerTalkCE
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.